IQVIA Nordics

IQVIA Nordics

Sjukhus och hälsovård

Solna, Sverige 8 617 följare

Om oss

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA Nordics has operation in Finland, Denmark, Norway and Denmark with close to 600 employees. IQVIA Nordics helps authorities, interest groups, pharmacies, hospitals, and companies in the pharmaceutical industry and MedTech to gain new insights and in-depth knowledge. To learn more, visit www.iqvia.com.

Webbplats
https://www.iqvia.com/
Bransch
Sjukhus och hälsovård
Företagsstorlek
Fler än 10 001 anställda
Huvudkontor
Solna, Sverige
Typ
Privatägt företag
Specialistområden
Master Data Management, Business Intelligence Applications, Cloud Services, Healthcare IT, Healthcare Consulting, Healthcare data, Business Intelligence, Real World Data, Clinical Research, Market Research, Market Access, Health Economics, CRM, Data Science, Research & Development, Commercial Effectivness och Advanced Analytics

Adresser

Anställda på IQVIA Nordics

Uppdateringar

  • IQVIA Nordics omdelade detta

    🔍 New report out now: Rethinking Clinical Trial Country Prioritization The biopharma clinical research ecosystem has undergone significant evolution over the past five years due to technological, environmental, societal, regulatory, and geopolitical shifts. These changes have reshaped clinical trial activities and operations, bringing both opportunities and challenges. 📊 Our latest report explores: ✅ The emergence of new global players in clinical trials. ✅ Execution challenges, delays, capacity concerns, and uncertainties impacting clinical development timelines and patient outcomes. ✅ The critical focus on global diversification of clinical trials. ✅ Trends in enrollment timelines, trial characteristics, and country utilization. ✅ Exploration of countries with high patient recruitment potential. Get your copy of the report: https://lnkd.in/erWtB-qG #ClinicalTrials #GlobalHealth #HealthEquity

    • Ingen alternativ bildtext i den här bilden
  • Visa organisationssidan för IQVIA Nordics, grafik

    8 617 följare

    #IQVIA today announced that LEO Pharma a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, has extended the contract for IQVIA’s Transparency Reporting solution to meet global transparency requirements across 22 countries. With this robust SaaS solution, the company can streamline their data integration from all sources, remediate and manage spend with in depth reporting tools, and utilize robust analytics to drive greater compliance insights, all on a single platform.   “LEO Pharma utilizes IQVIA's Transparency Reporting solution to streamline our global transparency reporting process, significantly reducing the time and resources previously devoted to the reporting process. The advanced analytics and user-friendly dashboards have empowered us to focus more on strategic growth while ensuring compliance with changing global regulations.” said the Head of HCP Compliance at LEO Pharma.   IQVIA Transparency Reporting is helping LEO Pharma keep up with consistently changing global transparency legislations, regulations, and codes, which is a major challenge for life sciences companies of all sizes. IQVIA’s Transparency Reporting makes reporting seamless with a user-friendly, intuitive process, and best-in-class SaaS technology, combined with continuous legal monitoring expertise that provides regulatory updates to stay compliant.   For more information on IQVIA Transparency Report, visit https://bit.ly/4f19RQI.

  • Visa organisationssidan för IQVIA Nordics, grafik

    8 617 följare

    Summer vacation is approaching, and here at IQVIA, we are looking forward to disconnecting and recharging our batteries after a busy first half of the year, with new customers, new consultants, and new agreements. We would like to wish our customers, partners, and consultants a great summer and look forward to new exciting tasks and challenges on the other side of the vacation. #WeAreIQVIA

    • Ingen alternativ bildtext i den här bilden
    • Ingen alternativ bildtext i den här bilden
    • Ingen alternativ bildtext i den här bilden
  • Visa organisationssidan för IQVIA Nordics, grafik

    8 617 följare

    June’s pharmaceutical market overview reports for Sweden, Norway and Finland are out! The overview includes monthly market growth rates, top health companies by sales, and detailed sales data for top products. The Finnish market saw a decline of 4.3%, with Orion Pharma leading in sales. The Norwegian market grew by 4.8%, with Novo Nordisk at the top. The Swedish market experienced a slight decline of 1.2%, with Janssen-Cilag leading. #IQVIANordics #pharmaceuticalmarket

  • Visa organisationssidan för IQVIA Nordics, grafik

    8 617 följare

    It's inspiring to see so many people with diverse perspectives and experiences come together at Almedalsveckan to discuss ideas and take action. We're particularly thrilled to see the focus on: -Implementing precision medicine -Attracting more clinical trials to Sweden -Optimizing healthcare flows and capacity, with patients and staff in focus These are all critical areas that will help improve healthcare outcomes and drive innovation in the industry. Let's continue to work together to make progress in these important areas. #IQVIANordics #Almedalen

    • Ingen alternativ bildtext i den här bilden
    • Ingen alternativ bildtext i den här bilden
  • Visa organisationssidan för IQVIA Nordics, grafik

    8 617 följare

    Käy kurkkaamassa meidän blogi ” EU:n rahoitus vauhdittamaan myös terveysalaa” ennen tiistain SuomiAreenaa. Rantalavalla EU-keskustelu jatkuu klo 16.00–16.45 aiheena "Kuka voittaa kansainvälisen kilpajuoksun lääketutkimuksista?". #IQVIANordics #SuomiAreena #TerveysOnTekoja

    ”EU:n rahoitusvälineiden käyttöön on valmistauduttava siten, että sidosryhmät olisivat sitoutuneet paremmin niiden käyttämiseen, sekä tehokkuuden varmistamiseksi, erityisesti terveydenhuollon digitaaliseen tulevaisuuteen”, kirjoittaa Susanna Flaherty (IQVIA) blogissaan. Lue lisää muun muassa terveysalan suunnitelluista investoinneista blogista: https://lnkd.in/dk8fF_NU #SuomiAreena2024 #TerveysOnTekoja #terveysala #EU

  • Visa organisationssidan för IQVIA Nordics, grafik

    8 617 följare

    Med stor glæde kan vi meddele, at IQVIA er blevet optaget på SKI´s dynamiske indkøbsaftale, 02.14 It-konsulenter.   Denne succes er delvist drevet af vores strategiske opkøb af Silverbullet, et skridt der har styrket vores position ved at tilføje et team af dygtige og erfarne konsulenter, der gør os i stand til at møde de offentlige myndigheders behov med endnu større kapacitet og specialiseret viden.   SKI-aftalen, bliver implementeret medio 2024. Vi glæder os til at bidrage til at forme fremtidens offentlige it-landskab ved hjælp af vores unikke kombination af analytisk indsigt og teknologisk ekspertise. #IQVIANordics

    • Ingen alternativ bildtext i den här bilden

Anslutna sidor

Liknande sidor